BDBM535778 US11236096, Example 56

SMILES Cc1cc(CC(=O)c2cn(c3ncnc(N)c23)C(C)(C)c2cccs2)n[nH]1

InChI Key InChIKey=ZGYGQOBLWQGUEB-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 535778   

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Taiho Pharmaceutical

US Patent
LigandPNGBDBM535778(US11236096, Example 56)
Affinity DataIC50: 0.279nMAssay Description:Regarding the conditions for measurement of in vitro inhibitory activity of compounds against RET kinase activity, the website of AnaSpec states that...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/6/2022
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Taiho Pharmaceutical

US Patent
LigandPNGBDBM535778(US11236096, Example 56)
Affinity DataIC50: 15.6nMAssay Description:Regarding the conditions for measurement of in vitro inhibitory activity of compounds against SRC kinase activity, the price list of LabChip-series c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/6/2022
Entry Details
US Patent

TargetTyrosine-protein kinase Lck(Human)
Taiho Pharmaceutical

US Patent
LigandPNGBDBM535778(US11236096, Example 56)
Affinity DataIC50: 1.65E+3nMAssay Description:Regarding the conditions for measurement of in vitro inhibitory activity of compounds against LCK kinase activity, the website of AnaSpec states that...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/6/2022
Entry Details
US Patent